NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH NCIBethesda, MD, 20892, USA

Original Source

https://sam.gov/opp/9fb1eb58dc5e4d3eb3d8d50be128e5e3/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), has issued a Special Notice regarding a subcontract opportunity at the Frederick National Laboratory for Cancer Research (FNLCR) aimed at enhancing laboratory practices to meet Good Clinical Laboratory Practice (GCLP) standards. The primary objective is to engage a subcontractor to evaluate current laboratory operations, identify compliance gaps, and implement improvements related to sample management, data integrity, and overall laboratory quality standards. This initiative is crucial for ensuring the integrity of testing and data management, which will facilitate the approval of new vaccine recommendations and enhance the laboratory's quality management system. Interested parties should note that this notice is for informational purposes only, with responses treated as government property, and are encouraged to monitor SAM.gov for updates. The deadline for submissions is January 3, 2025, at noon EST, and inquiries can be directed to Jennifer Gnuschke at jennifer.gnuschke@nih.gov.

    Point(s) of Contact
    Jennifer Gnuschke
    jennifer.gnuschke@nih.gov
    Files
    Title
    Posted
    H24-2526 SAM Special Notice.pdf
    S24-003 SAM Special Notice FINAL.docx
    S25-077 SAM Special Notice.docx
    The document details a Special Notice for subcontracting opportunities related to a Request for Proposal (RFP) aimed at enhancing laboratory practices at the Frederick National Laboratory for Cancer Research to meet Good Clinical Laboratory Practice (GCLP) standards. The National Institutes of Health's National Cancer Institute is seeking a subcontractor to evaluate current laboratory operations, identify compliance gaps, and implement improvements for GCLP adherence. Key objectives include assessing sample management, data integrity, and providing solutions to elevate laboratory quality standards. The project requires a review of existing procedures, clouding equipment maintenance and analyst competency assessments. The interested parties are informed that this notice is for informational purposes only, not a formal solicitation, with responses treated as government property without obligatory feedback or discussion from the government. Additionally, interested parties are encouraged to monitor SAM.gov and other relevant sites for updates and further opportunities related to the FNLCR. The response deadline is set for January 3, 2025, at noon EST.
    SAM Special Notice.docx
    SAM Special Notice - Solicitation H25-2531.pdf
    The document is a Special Notice regarding a Request for Proposal (RFP) for subcontracting opportunities related to the National Cancer Institute (NCI). It outlines the project titled "Wood Street Steam and Condensate Piping Replacement" at the Frederick National Laboratory for Cancer Research (FNLCR), located in Fort Detrick, Maryland. The relevant North American Industry Classification System (NAICS) code is 236220, emphasizing commercial and institutional building construction. The response deadline is set for December 16, 2024, and it is important to note that this notice serves informational purposes only and does not constitute a formal solicitation for bids. The FNLCR operates as a government-funded research center engaging in collaborative research aimed at developing new cancer and AIDS treatment methodologies. Interested parties are instructed to monitor the SAM.gov site for updates, as the government assumes no responsibility for costs incurred in responding to this notice. Further details regarding the project work specifications are also provided. Contact information for inquiries is available, indicating that the point of contact is Kim Abdinoor from Leidos Biomedical Research, Inc. This summary reflects the structured and regulatory nature of government-led projects, directed towards informing potential subcontractors of future opportunities without obliging them to respond formally.
    SAM Special Notice H24-2451.pdf
    SAM Special Notice S24-030.docx
    Similar Opportunities
    NHANES General Chemistry Laboratory Testing 2025-2030
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for the NHANES General Chemistry Laboratory Testing contract, which will span from February 14, 2025, to February 13, 2030. The primary objective of this procurement is to obtain Clinical Laboratory Improvement Amendments (CLIA) certified laboratory measurements on biological specimens collected through the National Health and Nutrition Examination Survey (NHANES), which aims to provide national statistics on the health and nutritional status of the U.S. population. This contract is crucial for generating national estimates and monitoring trends in chronic diseases, with the contractor responsible for conducting a variety of chemistry tests, including a Comprehensive Metabolic Panel and lipid panels, while ensuring strict confidentiality and compliance with ethical standards. Interested offerors must submit their proposals electronically by the specified deadlines, with a focus on demonstrating technical capabilities and relevant past performance, and can contact David Santimaw at zgm2@cdc.gov or 770-488-5282 for further information.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug products. The objective of this procurement is to secure high-quality formulated drug products to support preclinical, IND-enabling, and clinical studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is critical for advancing therapeutic development and enhancing the drug development pipeline, which is vital for public health. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can reach out to Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    NIAID Virology Quality Assurance
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a comprehensive quality assurance program for virologic assays related to HIV and other viral pathogens. The objective is to ensure the validity and comparability of laboratory data through proficiency testing panels and real-time assay controls, which are critical for ongoing and future studies on infectious diseases. This program has been operational since 1988 and supports approximately 110 laboratories globally, emphasizing the importance of maintaining high standards in virologic testing. Proposals are expected to be submitted electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the solicitation anticipated to be available on or about January 9, 2025. For further inquiries, interested parties can contact Shawnice Williams at shawnice.williams@nih.gov or Ashley Kinderdine at ashley.kinderdine@nih.gov.
    Notice of Intent for Laboratory Casework System
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is issuing a Notice of Intent for a sole source procurement of a Laboratory Casework System from Innovative Laboratory Systems. The requirement includes modular, durable, and customizable laboratory furniture that adheres to NIH Design Requirements Manual specifications and biosafety standards, ensuring it can withstand the demands of a research environment. The selected contractor will be responsible for delivery and installation services, maintenance support, and providing tailored training materials for laboratory staff, with the delivery location set for Hamilton, Montana. Interested parties capable of providing similar services must submit a capability statement by December 30, 2024, to Leah Hinson at leah.hinson@nih.gov, as the government intends to negotiate without full and open competition based on the authority of 41 U.S.C. 1901 (a) (1) and FAR 13.106-1.
    Clinical & Laboratory Standards Institute membership
    Active
    Commerce, Department Of
    The National Institute of Standards and Technology (NIST) intends to negotiate a sole source contract for a membership with the Clinical & Laboratory Standards Institute (CLSI) located in Berwyn, PA. This membership is crucial for NIST's Chemical Sciences Division, which relies on CLSI's extensive database to develop technical standards for the healthcare community, ensuring that NIST remains aligned with best practices in clinical laboratory testing. The resulting order will be a Firm-Fixed Price purchase order under NAICS code 561330, with a small business size standard of $36.5 million. Interested parties capable of fulfilling these requirements are invited to submit responses by December 24, 2024, with inquiries directed to Erik Frycklund at erik.frycklund@nist.gov or Donald Graham at donald.graham@nist.gov.
    NHLBI Procurement Forecast - FY2025-Q1 & Q2
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), has issued a special notice regarding its procurement forecast for the first and second quarters of Fiscal Year 2025. This notice outlines anticipated contracting opportunities, including a variety of goods and services such as scientific support services, IT security, and specialized scientific equipment, with a focus on fostering small business participation. The forecast serves as a planning tool for potential vendors, indicating that while the projected procurements are subject to change, they are essential for supporting the NIH's mission in health research. Interested parties can find detailed information, including estimated dollar values and points of contact, in the attached document, with initial award dates ranging from late 2024 to mid-2025.
    Synopsis of Proposed Contract Action
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for a contract focused on the development and testing of systems for the National Health and Nutrition Examination Survey (NHANES) chemistry data. The primary objectives include performing laboratory testing, specifically for a Comprehensive Metabolic Panel (CMP) and additional biochemical tests, while ensuring compliance with CLIA regulations and submitting results within 21 days of sample receipt. This initiative is crucial for enhancing public health data collection and management, with an estimated annual workload of 3,000 to 5,000 samples. Interested contractors must have active registration in the System for Award Management, and the solicitation is expected to be available on SAM.gov around December 16, 2024. For further inquiries, potential bidders can contact David Santimaw at zgm2@cdc.gov or 770-488-5282, or Arianna Williams at xsm2@cdc.gov or 770-488-5036.
    A--National Gene Vector Biorepository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) to support gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract aims to provide essential resources and services, including administrative management, core laboratory activities, and compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is crucial for advancing gene therapy capabilities and ensuring the proper archiving of biological specimens and development of assays. Proposals must be submitted by January 10, 2025, and should include detailed technical and business plans, with specific formatting guidelines and a budget submission required. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153.